Outcomes of patient education in adult oncologic patients receiving oral anticancer agents: a systematic review protocol

Abstract Background A large variety of oral anticancer agents have become available and while at first glance these therapies appear to provide only benefits, patients have expressed their need for educational interventions and raised safety issues. Although both patients and providers have recogniz...

Full description

Bibliographic Details
Main Authors: Federico Fonda, Sonja Cedrone, Ivana Sartor, Lucia Cadorin
Format: Article
Language:English
Published: BMC 2023-04-01
Series:Systematic Reviews
Subjects:
Online Access:https://doi.org/10.1186/s13643-023-02229-x
_version_ 1797841166925824000
author Federico Fonda
Sonja Cedrone
Ivana Sartor
Lucia Cadorin
author_facet Federico Fonda
Sonja Cedrone
Ivana Sartor
Lucia Cadorin
author_sort Federico Fonda
collection DOAJ
description Abstract Background A large variety of oral anticancer agents have become available and while at first glance these therapies appear to provide only benefits, patients have expressed their need for educational interventions and raised safety issues. Although both patients and providers have recognized patient education’s importance, and an interplay with safety has been acknowledged, no systematic reviews of the literature that summarize all of the current evidence related to patient education’s outcomes for patients who receive oral anticancer agents have been performed to date. Accordingly, this systematic review will attempt to fill the gap in the literature as well as to map (1) contents, (2) methodologies, (3) settings, (4) timing/duration, and (5) healthcare professionals involved. Methods This protocol is being reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. A systematic review will be performed. Studies that targeted eligible adult patients (≥ 18 years old) in hospital, outpatient, and home settings, and reported patient education’s outcomes for those taking oral anticancer agents will be included. Searches will be conducted in PubMed/MEDLINE, CINAHL, Embase, and Scopus, and gray literature will be also sought. Two researchers will screen the search results independently and blindly in two phases: (1) title/abstract screening and (2) full-text screening using the Rayyan AI platform. An electronic data extraction form will be implemented and piloted, and then, two trained data extractors will extract the data cooperatively. Thereafter, a quality appraisal will be conducted using the Critical Appraisal Tools from The Joanna Briggs Institute. The results will be analyzed, grouped, clustered into categories, and discussed until a consensus is reached. Emerging evidence will be synthesized narratively and reported in accordance with the synthesis without meta-analysis guidelines. Discussion The systematic review’s results will be relevant to (1) policymakers and management at an institutional level, and (2) for clinical practice, in an evidence-based paradigm, potentially leading to a quality improvement with respect to safety and patient satisfaction. Systematic review registration PROSPERO CRD42022341797
first_indexed 2024-04-09T16:26:41Z
format Article
id doaj.art-aedd2c252e0c49d2ae4e9948d4e9c409
institution Directory Open Access Journal
issn 2046-4053
language English
last_indexed 2024-04-09T16:26:41Z
publishDate 2023-04-01
publisher BMC
record_format Article
series Systematic Reviews
spelling doaj.art-aedd2c252e0c49d2ae4e9948d4e9c4092023-04-23T11:10:42ZengBMCSystematic Reviews2046-40532023-04-011211710.1186/s13643-023-02229-xOutcomes of patient education in adult oncologic patients receiving oral anticancer agents: a systematic review protocolFederico Fonda0Sonja Cedrone1Ivana Sartor2Lucia Cadorin3Department of Anaesthesia and Intensive Care, Azienda Sanitaria Universitaria Friuli Centrale, University Hospital of UdineCentro di Riferimento Oncologico di Aviano (CRO) IRCCSCentro di Riferimento Oncologico di Aviano (CRO) IRCCSCentro di Riferimento Oncologico di Aviano (CRO) IRCCSAbstract Background A large variety of oral anticancer agents have become available and while at first glance these therapies appear to provide only benefits, patients have expressed their need for educational interventions and raised safety issues. Although both patients and providers have recognized patient education’s importance, and an interplay with safety has been acknowledged, no systematic reviews of the literature that summarize all of the current evidence related to patient education’s outcomes for patients who receive oral anticancer agents have been performed to date. Accordingly, this systematic review will attempt to fill the gap in the literature as well as to map (1) contents, (2) methodologies, (3) settings, (4) timing/duration, and (5) healthcare professionals involved. Methods This protocol is being reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. A systematic review will be performed. Studies that targeted eligible adult patients (≥ 18 years old) in hospital, outpatient, and home settings, and reported patient education’s outcomes for those taking oral anticancer agents will be included. Searches will be conducted in PubMed/MEDLINE, CINAHL, Embase, and Scopus, and gray literature will be also sought. Two researchers will screen the search results independently and blindly in two phases: (1) title/abstract screening and (2) full-text screening using the Rayyan AI platform. An electronic data extraction form will be implemented and piloted, and then, two trained data extractors will extract the data cooperatively. Thereafter, a quality appraisal will be conducted using the Critical Appraisal Tools from The Joanna Briggs Institute. The results will be analyzed, grouped, clustered into categories, and discussed until a consensus is reached. Emerging evidence will be synthesized narratively and reported in accordance with the synthesis without meta-analysis guidelines. Discussion The systematic review’s results will be relevant to (1) policymakers and management at an institutional level, and (2) for clinical practice, in an evidence-based paradigm, potentially leading to a quality improvement with respect to safety and patient satisfaction. Systematic review registration PROSPERO CRD42022341797https://doi.org/10.1186/s13643-023-02229-xPatient educationOutcomesOral anticancer agentsCancerSystematic review protocol
spellingShingle Federico Fonda
Sonja Cedrone
Ivana Sartor
Lucia Cadorin
Outcomes of patient education in adult oncologic patients receiving oral anticancer agents: a systematic review protocol
Systematic Reviews
Patient education
Outcomes
Oral anticancer agents
Cancer
Systematic review protocol
title Outcomes of patient education in adult oncologic patients receiving oral anticancer agents: a systematic review protocol
title_full Outcomes of patient education in adult oncologic patients receiving oral anticancer agents: a systematic review protocol
title_fullStr Outcomes of patient education in adult oncologic patients receiving oral anticancer agents: a systematic review protocol
title_full_unstemmed Outcomes of patient education in adult oncologic patients receiving oral anticancer agents: a systematic review protocol
title_short Outcomes of patient education in adult oncologic patients receiving oral anticancer agents: a systematic review protocol
title_sort outcomes of patient education in adult oncologic patients receiving oral anticancer agents a systematic review protocol
topic Patient education
Outcomes
Oral anticancer agents
Cancer
Systematic review protocol
url https://doi.org/10.1186/s13643-023-02229-x
work_keys_str_mv AT federicofonda outcomesofpatienteducationinadultoncologicpatientsreceivingoralanticanceragentsasystematicreviewprotocol
AT sonjacedrone outcomesofpatienteducationinadultoncologicpatientsreceivingoralanticanceragentsasystematicreviewprotocol
AT ivanasartor outcomesofpatienteducationinadultoncologicpatientsreceivingoralanticanceragentsasystematicreviewprotocol
AT luciacadorin outcomesofpatienteducationinadultoncologicpatientsreceivingoralanticanceragentsasystematicreviewprotocol